Despite EC Switch Denial, Attorneys See Value In Non-Sponsor Petitions
This article was originally published in The Tan Sheet
You may also be interested in...
AAP Presses FDA To Eliminate OTC Pediatric Combination Products
The American Academy of Pediatrics wants FDA to eliminate OTC combination pediatric cough/cold products.
Antihistamine Forced Switch Proposal Returns In Citizen Petition
A law firm seeks to cut its own health care costs as well as direct FDA's attention to previous citizen petitions to switch Rx antihistamines to OTC with a petition asking FDA to switch Sanofi-Aventis's Allegra and Pfizer's Zyrtec
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.